Düsseldorf, October 30, 2014 – Gerresheimer manufactures a comprehensive range of glass and plastic pharmaceutical primary packaging products and drug delivery systems, including auto-injectors, asthma inhalers, insulin pens and lancing devices, for many reputed companies in the pharmaceutical industry. At Compamed 2014 from November 12 to 14 the company will be showcasing its products and services on Stand G31 in Hall 8b.
Quality by Design (QbD) is a process by which quality is systematically built into a product and production process during the development phase. When applied consistently, it is the most reliable and cost-effective way to bring complex products to the market. Pharmaceutical and medical technology specialist Gerresheimer has an integrated tool qualification and validation strategy in place so that it can develop products to the marketing stage quickly and cost efficiently. It also provides a process window for stable series production and options for different application scenarios and qualification levels.
Pharmaceutical and medical technology products have to go through lengthy licensing procedures in advance of series production and small quantities of the product have to be regularly produced as clinical samples or stability batches. Gerresheimer Medical Plastic Systems opened its own Technical Competence Center in Wackersdorf for small batch production. The TCC manufactures products in series quality and the knowledge gained can then be directly incorporated in the mass production process at the Gerresheimer facility of the customer’s choice.
Only recently a major pharmaceuticals corporation requested Gerresheimer to manufacture an auto-injector. It is manufactured at the Gerresheimer Küssnacht plant in Switzerland. The auto-injector is composed of fourteen plastic components and three metal parts. The plastic parts are produced by Gerresheimer, then made into two subassemblies for final assembly and filling on the customer’s premises. The pharmaceutical drug is for the treatment of medium to serious active psoriasis arthritis.
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with 11,000 employees and manufacturing operations in the local markets, close to customers. It has over 40 production facilities in Europe, North and South America and Asia generating revenue in excess of EUR 1.2 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.